86 related articles for article (PubMed ID: 8867478)
1. [Ciprofloxacin in treatment of common bacterial skin infections. Results of an open study in general practice].
Braun H
Fortschr Med; 1996 Feb; 114(5):55-6. PubMed ID: 8867478
[No Abstract] [Full Text] [Related]
2. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Nicodemo AC; Robledo JA; Jasovich A; Neto W
Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
[TBL] [Abstract][Full Text] [Related]
3. Topical ciprofloxacin in long-lasting otorrhea.
Manestar D; Braut T; Velepic M
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):236. PubMed ID: 10037296
[No Abstract] [Full Text] [Related]
4. Cutaneous anthrax: a concise review.
Tutrone WD; Scheinfeld NS; Weinberg JM
Cutis; 2002 Jan; 69(1):27-33. PubMed ID: 11829175
[TBL] [Abstract][Full Text] [Related]
5. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Goffin E; Pouthier D; Vandercam B; Gigi J; van Ypersele de Strihou C
Clin Nephrol; 1997 Dec; 48(6):391-2. PubMed ID: 9438101
[No Abstract] [Full Text] [Related]
6. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
7. Single dose ciprofloxacin in cholera.
Usubütün S; Ağalar C; Diri C; Türkyilmaz R
Eur J Emerg Med; 1997 Sep; 4(3):145-9. PubMed ID: 9426995
[TBL] [Abstract][Full Text] [Related]
8. Treatment of soft tissue infections in gynecology by comparison 3 vs 7 day therapy with ciprofloxacin.
Weissenhacher ER; Gotz A; Braun H; Gutschow K; Wachter I
J Chemother; 1989 Jul; 1(4 Suppl):889. PubMed ID: 16312689
[No Abstract] [Full Text] [Related]
9. A case report of highly suspected ciprofloxacin-induced hepatotoxicity.
Bhagirath KM
Turk J Gastroenterol; 2008 Sep; 19(3):204-6. PubMed ID: 19115163
[No Abstract] [Full Text] [Related]
10. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
[TBL] [Abstract][Full Text] [Related]
11. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients.
Moysés Neto M; Costa RS; Reis MA; Ferraz AS; Saber LT; Batista ME; Muglia V; Garcia TM; Figueiredo JF
Clin Transplant; 1997 Oct; 11(5 Pt 1):446-52. PubMed ID: 9361939
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-induced vasculitis.
Reaño M; Vives R; Rodríguez J; Daroca P; Canto G; Fernández J
Allergy; 1997 May; 52(5):599-600. PubMed ID: 9201380
[No Abstract] [Full Text] [Related]
13. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
14. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
15. [The effectiveness of ciprofloxacin in bacterial skin infections].
Meisel C; Blenk H
Z Hautkr; 1988 Dec; 63(12):1016-22. PubMed ID: 3218288
[TBL] [Abstract][Full Text] [Related]
16. [Ciprofloxacin-induced acute non-oliguric renal failure in patient with chronic glomerulonephritis].
Paszkowska M; Niemir ZI; Nowak A; Czekalski S
Wiad Lek; 2005; 58(1-2):131-3. PubMed ID: 15991567
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
De Wilde R
J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
[No Abstract] [Full Text] [Related]
18. Dose adjustment of ciprofloxacin in renal failure: reduce the dose or prolong the administration interval?
Czock D; Rasche FM
Eur J Med Res; 2005 Apr; 10(4):145-8. PubMed ID: 15946909
[TBL] [Abstract][Full Text] [Related]
19. [Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension].
García Victor F; Ferrero Doria R
Arch Esp Urol; 2001 May; 54(4):313-20. PubMed ID: 11455764
[TBL] [Abstract][Full Text] [Related]
20. Avoiding adverse reactions.
Lilley LL; Guanci R
Am J Nurs; 1996 Sep; 96(9):18-20. PubMed ID: 8855906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
